Home/ Supplements/ Bromelain/ Protrypsin

Protrypsin

product on market Tablet or Pill Metagenics Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Protrypsin
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
30
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Chymotrypsin
Trypsin
Raw Pancreas Concentrate
100 mg
133 mg
Market median: 200.0mg (136 products) 3 studies — no high-quality reviews

Other Ingredients

Microcrystalline Cellulose Stearic Acid Croscarmellose Sodium Silica Enteric Coating
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take two tablets one to three times daily between meals or as directed by your healthcare practitioner.

Warnings & Precautions

Caution: If pregnant or nursing, consult your healthcare practitioner before use if taking other nutritional supplements or medications.

Do not use if there is a prior history of or a current peptic or duodenal ulcer.

Keep out of the reach of children.

Do not use in individuals who have a known allergy or hypersensitivity to pork or pork protein.

Contains: Milk.

Formulation Notes

Protrypsin is a potent, enteric-coated proteolytic enzyme formula featuring premium-grade chymotrypsin and trypsin to support tissue health.

This product is non-GMO and gluten-free.

Support for tissue health

Additional Information

Storage: To help maintain potency after opening, keep this bottle tightly closed and store in a cool, dry place. Do not refrigerate. Refrigeration may cause moisture condensation on the product.

GF Certified Gluten-free

Practitioner exclusive

Metadata

Product Details

UPC / SKU7 55571 91036 3
DSLD Entry Date2020-03-24
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
DSLD ID216280
Data Updated2026-04-11
Research

Research Evidence

1
Research Sources
52
Avg Quality
1
Systematic Review
C The role of Bromelain and Liposomal Vitamin C in the treatment of chronic venous disease
Systematic Review VASA. Zeitschrift fur Gefasskrankheiten 2025 PubMed DOI
View all evidence for Bromelain →
Compare

Similar Products

View all Bromelain products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.